Our History | SapiensBio Sapiensbio skip to Main Content

About us

Data-Driven Technology-Based Drug Discovery Solution

Our History

Making a better world with innovative data-driven drug discovery and development.


Growth Stage

  • Selected as Presenting Company in Bio Europe 2022
  • Selected as Presenting Company in Bio USA 2022
  • 2 Patents submitted: Composition of matter
  • Signed a joint R&D agreement with ADDI in UK
  • Launched an innovative machine learning & wet lab workflow drug discovery platform, Sapientia
  • Set up a new company name : SapiensBio, Inc.


Research and Evaluation Stage

  • Novel Target Identification & Validation
  • Patent submitted: Composition of matter
  • Participated in Bio USA 2021
  • Started fibrosis & Alzheimer’s disease treatment

2019 ~ 2020

Development stage

  • Obtained Venture Business and Corporate R&D Institute Certifications
  • Invented new AI drug discovery platform, Sapientia


Foundation stage

  • Establishment of SapiensBio, Inc.
Back To Top